Related Experiment Video
Updated: Jul 22, 2026
06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
Antidiabetic therapies and male reproductive function: where do we stand?
R S Tavares1,2, S Escada-Rebelo1,3, A F Silva1
1Biology of Reproduction and Stem Cell GroupCNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
Reproduction (Cambridge, England)
|October 11, 2017
Summary
The impact of antidiabetic drugs on male reproductive health is unclear, with conflicting study results. Further research is needed to ensure the safety of these treatments for young men with diabetes.
Area of Science:
- Endocrinology
- Reproductive Medicine
- Pharmacology
Background:
- Diabetes mellitus is a growing global health concern.
- Antidiabetic drugs manage glycemic levels and prevent complications.
- Male reproductive dysfunction is linked to diabetes, impacting fertility, especially in young men.
Purpose of the Study:
- To critically analyze the effects of various antidiabetic drugs on male reproductive function.
- To highlight the need for maintaining reproductive health in diabetic individuals undergoing treatment.
- To address the scarcity of research on this topic.
Main Methods:
- A comprehensive review and critical analysis of existing scientific literature.
- Examination of studies investigating the influence of antidiabetic therapies on male reproductive parameters.
- Assessment of the coherence and controversy in reported findings.
Main Results:
- Insulin has a defined role in male reproductive function.
- The effects of other antidiabetic therapies on male reproduction are inconsistent and controversial.
- Discrepancies may stem from varied experimental approaches.
Conclusions:
- Caution is advised when prescribing antidiabetic drugs to young diabetic patients due to uncertain reproductive effects.
- More research is essential to determine the safety of these treatments on the male reproductive system.
- The impact of insulin level variations and hypoglycemia on male reproductive health requires further investigation.
Related Concept Videos
01:23Infertility in Males
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...